Scalper1 News
Big-cap biotech Amgen (AMGN) offered 2015 guidance, set 2018 targets and resisted pressure to split at a business-review meeting Tuesday. On the heels of Monday’s Q3 earnings beat, Amgen’s action helped drive the stock up more than 5% in afternoon trading on the stock market today to a new high above 156. Amgen guided 2015 revenue at $20.8 billion to $21.3 billion, above analyst consensus of $20.4 billion. It guided EPS at $9.05 to $9.40, beating Scalper1 News
Scalper1 News